⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QURE News
uniQure N.V.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE
globenewswire.com
QURE
QURE Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against uniQure N.V.
prnewswire.com
QURE
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
QURE
ATTENTION NASDAQ: QURE INVESTORS: Contact Berger Montague About an uniQure N.V. Class Action Lawsuit
globenewswire.com
QURE
Pomerantz LLP Advises Investors of Class Action Filing Against uniQure N.V. – QURE
accessnewswire.com
QURE
QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
QURE
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit
prnewswire.com
QURE
uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE
prnewswire.com
QURE
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
QURE
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
accessnewswire.com
QURE